Exploiting the Body's Immune System to Treat a Broad Range of Diseases

Read more

ARMO in the News

12/29/17 — ARMO BioSciences Files Registration Statement for Proposed Initial Public Offering  Read more

12/9/17 — ARMO BioSciences Presents Updated Data at ESMO Immuno Oncology Conference on RCC and NSCLC

11/28/17 — ARMO BioSciences Appoints Herb Cross as Chief Financial Officer  Read more

8/29/17 — ARMO BioSciences Raises $67 Million in a Series C-1 Financing  Read more